Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 966-976

  Watts, Val J ^a,b   Neve, Kim A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; BROMOCRIPTINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; PERGOLIDE; PROPRANOLOL; QUINPIROLE; SPIPERONE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GLIOMA; HUMAN; HUMAN CELL; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADENYLATE CYCLASE; CELLS, CULTURED; CYCLIC AMP; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FORSKOLIN; HUMANS; ISOENZYMES; ISOPROTERENOL; KINETICS; RECEPTORS, DOPAMINE D2; RECOMBINANT PROTEINS; SECOND MESSENGER SYSTEMS; SENSITIVITY AND SPECIFICITY; SPIPERONE; STIMULATION, CHEMICAL; TETRAHYDRONAPHTHALENES;

EID: 0029860160     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Gilman, A. G. G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56:615-649 (1987).
2. Sharma, S. K., W. A. Klee, and M. Nirenberg. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:3092-3096 (1975).
3. Reisine, T. D., and J. S. Takahashi. Somatostatin pretreatment desensitizes somatostatin receptors linked to adenylate cyclase and facilitates the stimulation of cyclic adenosine 3′:5′-monophosphate accumulation in anterior pituitary tumor cells. J. Neurosci. 4:812-819 (1984).
4. 2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Mol. Pharmacol. 39:55-63 (1991).
5. Hadcock, J. R., and C. C. Malbon. Agonist regulation of gene expression of adrenergic receptors and G proteins. J. Neurochem. 60:1-9 (1993).
6. Thomas, J. M., and B. B. Hoffman. Adenylate cyclase superaensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol. Sci. 8:308-311 (1987).
7. 2-adrenergic receptors. J. Biol. Chem. 268:11915-11922 (1991).
8. Ammer, H., and R. Schulz. Alterations in the expression of G-proteins and regulation of adenylate cyclase in human neuroblastoma SH-SY5Y cells chronically exposed to low-efficacy μ-opioids. Biochem. J. 295:263-271 (1993).
9. Reithmann, C., and K. Werdan. Chronic muscarinic cholinoceptor stimulation increases adenylyl cyclase responsiveness in rat cardiomyocytes by a decrease in the level of inhibitory G-protein α-subunits. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:27-34 (1995).
10. Milligan, G. Agonist regulation of cellular G protein levels and distribution: mechanisms and functional implications. Trends Pharmacol. Sci. 14:413-418 (1993).
11. Meeker, R. B., and T. K. Harden. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism: agonist-induced changes in nucleotide synthesis and degradation. Mol. Pharmacol. 23:384-392 (1983).
12. 2-Adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production. Proc. Natl. Acad. Sci. USA 84:1294-1298 (1987).
13. 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cells. J. Biol. Chem. 263:14236-14244 (1988).
14. 2-adrenergic receptor phosphorylation and increases β-adrenergic responsiveness. J. Biol. Chem. 267:8468-8472 (1992).
15. 2 receptors in a novel cell line (SUP1). Mol. Pharmacol. 39:531-539 (1991).
16. 2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells. J. Pharmacol. Exp. Ther. 271:1574-1582 (1994).
17. 2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol. Pharmacol. 45:878-389 (1994).
18. 3 receptor. Synapse 21:1-9 (1995).
19. 2 receptors on cultured cells. J. Neurochem. 65:569-577 (1995).
20. Morgenstern, J. P., and H. Land. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596 (1990).
21. Sabol, S. L., and M. Nirenberg. Regulation of adenylate cyclase of neuroblastoma × glioma hybrid cells by α-adrenergic receptors. II. Long lived increase of adenylate cyclase activity mediated by a receptors. J. Biol. Chem. 254:1921-1926 (1979).
22. Heisler, S., and C. B. Srikant. Somatostatin-14 and somatostatin-28 pretreatments down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3′,5′-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells. Endocrinology 117:217-225 (1985).
23. 2-adrenergic receptors accelerates loss of response to norepinephrine in primary glial cultures. Mol. Pharmacol. 41:688-694 (1992).
24. Nordstedt, C., and B. B. Fredholm. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Anal. Biochem. 189:231-234 (1990).
25. + exchange assessed by quantification of extracellular acidification. J. Biol Chem. 267:25748-25753 (1992).
26. B-mediated signal transduction in S49 lymphoma cells treated with inhibitors of microtubules. J. Biol. Chem. 268:3833-3837 (1993).
27. Filtz, T. M., R. P. Artymyshyn, W. Guan, and P. B. Molinoff. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol. Pharmacol. 44:371-379 (1993).
28. 2L receptor in human embryonic kidney 293 cells. Mol. Pharmacol. 48:956-964 (1995).
29. Hazlerigg, D. G., A. Gonzalez-Brito, W. Lawson, M. H. Hastings, and P. J. Morgan. Prolonged exposure to melatonin leads to time-dependent sensitization of adenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 132:285-292 (1993).
30. Thomas, J. M., and B. B. Hoffman. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol. Pharmacol. 49:907-914 (1996).
31. Seamon, K. B., and J. W. Daly. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7:201-224 (1981).
32. Darfler, F. J., L. C. Mahan, A. M. Koachman, and P. A. Insel. Stimulation by forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J. Biol. Chem. 257:11901-11907 (1982).
33. 6-2B cells. Mol. Pharmacol. 25:256-260 (1984).
34. Battaglia, G., A. B. Norman, E. J. Hess, and I. Creese. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride. J. Neurochem. 46:1180-1185 (1986).
35. 3H]forskolin binding in membranes from HT29 cells. Biochem. Pharmacol. 40:871-877 (1990).
36. 6 glioma cells. J. Biol. Chem. 257:3739-3746 (1982).
37. Xia, Z., E. J. Choi, F. Wang, and D. R. Storm. The type III calcium/ calmodulin-sensitive adenylyl cyclase is not specific to olfactory sensory neurons. Neurosci. Lett. 144:169-173 (1992).
38. 6-2B glioma cells may account for calcium inhibition of cAMP accumulation. Biochem. J. 295:325-328 (1993).
39. Choi, E.-J., W. T. Wong, T. R. Hinds, and D. R. Storm. Calcium and muscarinic agonist stimulation of type I adenylylcyclase in whole cells. J. Biol. Chem. 267:12440-12442 (1992).
40. Tang, W.-J., and A. G. Gilman. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science (Washington D. C.) 254:1500-1502 (1991).
41. Taussig, R., L. M. Quarmby, and A. G. Gilman. Regulation of purified type I and type II adenylylcyclases by G protein βγ subunits. J. Biol. Chem. 268:9-12 (1993).
42. Jacobowitz, O., and R. Iyengar. Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc. Natl. Acad. Sci. USA 91: 10630-10634 (1994).
43. B-coupled receptors in vivo. J. Biol. Chem. 269:25400-25405 (1994).
44. 2 purinergic and M5 muscarinic receptor agonists in L cells. Mol. Pharmacol 39:539-546 (1991).
45. Rasenick, M. M., and N. Wang. Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction. J. Neurochem. 51:300-311 (1988).
46. Rodbell, M. The role of GTP-binding proteins in signal transduction: from the sublimely simple to the conceptually complex. Curr. Top. Cell. Regul. 32:1-47 (1992).
47. Neubig, R. R. Membrane organization in G-protein mechanisms. FASEB J. 8:939-946 (1994).
48. 1 receptor system in neuroblastoma × glioma (NG108-15) hybrid cells. J. Neurochem. 64:2449-2457 (1995).
49. Chen, J., and M. M. Rasenick. Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J. Pharmacol. Exp. Ther. 275:509-517 (1995).